Multiple hormones (e.g., angiotensin II, aldosterone), growth factors (e.g., IGF-1) and transcription factors (e.g., NRSF and Nkx2.5) involved in cardiac disease progression have been shown to regulate the expression of TTCCs in cardiomyocytes [2]. This evidence concerns the gene REST and heart disorder.